SCHEMBL3923944

SCHEMBL3923944

CC(=O)OC1COc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
HCRTR2 O43614 1/20 0.40
MTNR1A P48039 1/20 0.40
LTB4R Q15722 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.39
SSTR4 P31391 1/20 0.39
CYP19A1 P11511 1/20 0.38
NOX1 Q9Y5S8 1/20 0.38
HTR2B P41595 3/20 0.38
CYP3A4 P08684 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
CYP2D6 P10635 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3930074 1.00 POLB (0.46) POLBHCRTR2MTNR1ALTB4RLTB4R2
SCHEMBL75403 0.84 HCRTR2 (0.37) POLBHCRTR2MTNR1ALTB4RLTB4R2
SCHEMBL30812977 0.84 POLB (0.44) POLBSSTR4GAASMN1; SMN2
SCHEMBL9785817 0.84 POLB (0.44) POLBSSTR4GAASMN1; SMN2
SCHEMBL28008010 0.84 POLB (0.44) POLBMTNR1AGABRA1GABRB2KMT2A
SCHEMBL27594439 0.83 HCRTR2 (0.40) HCRTR2LTB4RLTB4R2SSTR4CYP19A1
SCHEMBL19719096 0.83 HTR2B (0.41) POLBHCRTR2MTNR1ALTB4RLTB4R2
SCHEMBL11870882 0.80 SSTR4 (0.38) HCRTR2LTB4RLTB4R2SSTR4CYP19A1
SCHEMBL10444322 0.80 MTNR1A (0.34) POLBHCRTR2MTNR1ACYP3A4KMT2A
SCHEMBL31460771 0.80 HCRTR2 (0.49) HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166114-A Cyclic tetramer compounds as proprotein convertase subtilisin/KEXIN 9 type (PCSK9) inhibitors for the treatment of metabolic disorders 诺华股份有限公司 2021-07-23 CN disclosed
CN-104507921-A Benzocyclobutene derivative and preparation method and pharmaceutical application thereof SICHUAN HAISCO PHARMACEUTICAL CO LTD 2015-04-08 CN disclosed
EP-2041123-A2 FUSED CYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2009-04-01 EP disclosed
WO-2008001931-A2 FUSED CYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-03 WO disclosed
US-4720559-A Certain 2,3-dihydobenzofuran-3-yl acetic acids and their method of preparation EASTMAN KODAK COMPANY (US) 1988-01-19 US disclosed